Item List

Medical technology companies Rhisa and Gradient Health join forces to accelerate healthcare innovation by providing a new scale of diverse data to researchers from around the world.

Artificial intelligence (AI) has the potential to revolutionize medical technology, however its effectiveness can be hampered by using small, unrepresentative training datasets. This issue is also warranting significant attention from regulators, meaning developers now need to be sure their AI products have been trained on sufficiently diverse datasets before they can secure FDA or CE clearances.